Appetite, glucose, metabolic, and energy-balance pathways under study.
33 results
Individual peptide
5-Amino-1MQ is examined in studies of nutrient handling and body-composition pathways.
Level 2 · Animal Research
Claim: Appetite and glucose-regulation signaling
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Rodent metabolic studies; no published human trials.
View evidence map →Individual peptide
Research interest in Adipotide centres on energy balance and metabolic-rate pathways.
Level 2 · Animal Research
Claim: Appetite and glucose-regulation signaling
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Animal obesity studies; human development halted.
View evidence map →Individual peptide
Research interest in AICAR centres on energy balance and metabolic-rate pathways.
Level 2 · Animal Research
Claim: Appetite and glucose-regulation signaling
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Animal exercise-mimetic studies; human use restricted in sport.
View evidence map →Individual peptide
Research interest in AOD-9604 centres on energy balance and metabolic-rate pathways.
Level 4 · Controlled Human Studies
Claim: Appetite and glucose-regulation signaling
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Randomized human trials conducted for obesity; results were modest.
View evidence map →Individual peptide
Researchers are studying Cagrilintide in relation to appetite signaling and glucose regulation.
Level 4 · Controlled Human Studies
Claim: Appetite and glucose-regulation signaling
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Randomized controlled trials alone and with semaglutide.
View evidence map →Blend · 2 components
This blend is examined in studies of nutrient handling and body-composition pathways.
Published evidence — exact blend
Not yet reviewed
Components (reviewed separately)
Individual peptide
CJC-1295 with DAC is examined in studies of nutrient handling and body-composition pathways.
Level 3 · Early Human Research
Claim: Appetite and glucose-regulation signaling
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Small early human pharmacology studies of growth hormone release.
View evidence map →Individual peptide
Researchers are studying CJC-1295 without DAC in relation to appetite signaling and glucose regulation.
Level 3 · Early Human Research
Claim: Appetite and glucose-regulation signaling
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Small early human pharmacology studies; limited clinical data.
View evidence map →Blend · 2 components
Researchers are studying this blend in relation to appetite signaling and glucose regulation.
Published evidence — exact blend
Not yet reviewed
Components (reviewed separately)
Individual peptide
Eloralintide is examined in studies of nutrient handling and body-composition pathways.
Level 3 · Early Human Research
Claim: Appetite and glucose-regulation signaling
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Early-phase human trials underway; no controlled outcome data published yet.
View evidence map →Other research compound
Researchers are studying this compound in relation to appetite signaling and glucose regulation.
Not yet reviewed
Claim: Appetite and glucose-regulation signaling
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Evidence assessment pending editorial review.
View evidence map →Individual peptide
Research interest in GHRP-2 Acetate centres on energy balance and metabolic-rate pathways.
Level 3 · Early Human Research
Claim: Appetite and glucose-regulation signaling
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Early human growth hormone secretagogue studies.
View evidence map →Every result card shows the same five-segment bar. Each level below matches the color of that segment.
Level 1: Laboratory Research
Observed in cells, tissue, or computational models only.
Level 2: Animal Research
Studied in animal models; results often do not transfer to people.
Level 3: Early Human Research
Human research
Small, early-stage, or uncontrolled studies in humans.
Level 4: Controlled Human Studies
Human research
Randomized or otherwise controlled human trials exist.
Level 5: Regulatory Review or Established Clinical Use
Human research
Reviewed by a regulator or established in clinical practice for a specific use.
Evidence is rated by claim—not popularity. More studies do not always mean stronger evidence.
A higher level describes research maturity. It is not a recommendation or endorsement.
Educational information only. Not medical advice.
0 peptides selected
Select up to 6 peptides to compare.